Stock profile

Hikma Pharmaceuticals PLC

HIK.LSE LSE GBX ISIN GB00B0LCW083

Market tone: Positive sentiment score 1.00 from 1 mentions, latest 03 Apr 2026.

Open 1,531.00p Prev close 1,515.00p Volume 260,322

Recent Dividends

Dividend37.2pFinal Event yield1.71% - 1.85%declared to ex-div Ex-div drop-2.79%price move Decl26 Feb Ex-div20 Mar Pay01 May

Dividend27.3pInterim Event yield1.51% - 1.57%declared to ex-div Ex-div drop-1.21%price move Decl07 Aug Ex-div14 Aug Pay18 Sep

Dividend35.3pFinal Event yield2.57% - 2.96%declared to ex-div Ex-div drop-3.11%price move Decl26 Feb Ex-div19 Mar Pay30 Apr

Price History 05 Dec 2024 to 24 Jun 2026

1,099.08 1,432.29 1,765.50 2,098.71 2,431.92 Jan 25 Apr 25 Jul 25 Oct 25 Jan 26 Apr 26 Decl 26 Feb Ex 20 Mar Pay 01 May Decl 07 Aug Ex 14 Aug Pay 18 Sep Decl 26 Feb Ex 19 Mar Pay 30 Apr

37.2p Final

Declared: 26 Feb
Ex-div: 20 Mar
Yield: 1.71%–1.85%
Ex-drop: -2.79%
Paid: 01 May

27.3p Interim

Declared: 07 Aug
Ex-div: 14 Aug
Yield: 1.51%–1.57%
Ex-drop: -1.21%
Paid: 18 Sep

35.3p Final

Declared: 26 Feb
Ex-div: 19 Mar
Yield: 2.57%–2.96%
Ex-drop: -3.11%
Paid: 30 Apr

News

EODHD feed

09 Jun 2026 Positive 1.00 [Latest] Global Generic Drug Market Size/Share Worth USD 926.54 Billion by 2034 at a 6.55% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Generic Drug Market size Generic Drugs Growth Rate Market Research Reports Market Analysis 04 Jun 2026 Positive 1.00 Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma LONDON, June 4, 2026 /PRNewswire/ -- Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc., (Hikma) offered the following comments on tod Fda Approval Generic Medicines Patent Litigation Pharmaceuticals 01 Jun 2026 Positive 1.00 Hikma Pharmaceuticals Announces Major Expansion in Ohio, Creating 350 New Jobs and Investing $267 Million Cleveland and Columbus, Ohio, June 01, 2026 (GLOBE NEWSWIRE) -- COLUMBUS and CLEVELAND, Ohio – Ohio Governor Mike DeWine, along with Hikma Pharmaceuticals, JobsOhio, the City of Company Announcement Government News Jobs Manufacturing 01 Jun 2026 Positive 1.00 Hikma Pharmaceuticals Announces Major Expansion in Ohio, Creating 350 New Jobs and Investing $267 Million Cleveland and Columbus, Ohio, June 01, 2026 (GLOBE NEWSWIRE) -- COLUMBUS and CLEVELAND, Ohio – Ohio Governor Mike DeWine, along with Hikma Pharmaceuticals, JobsOhio, the City of Be Job Creation Manufacturing Ohio Pharmaceuticals 19 May 2026 Positive 1.00 How The Hikma Pharmaceuticals (LSE:HIK) Narrative Is Shifting After Analyst Valuation Resets Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Hikma P Guidance Price Target Price Target Ratings 30 Apr 2026 Positive 0.99 Pfizer (PFE) Reaches Settlement to Extend VYNDAMAX Patent Protection Until 2031 Pfizer Inc. (NYSE:PFE) is one of the most active US stocks to buy right now. On April 28, Pfizer entered into settlement agreements with generic drug manufacturers Dexcel Pharma, H Cardiovascular Litigation Patent Protection Pharmaceuticals

Historical Dividends

Total dividends and yield-at-ex-date by year

Payout trend 14.39% Growing · 2021-2025 payout CAGR

Payout volatility 20.60% Variable · std dev / average payout

Peak payout68.3p

Peak annual yield4.79%

2021

1.58%

37.7p

18 Mar 24.7p 19 Aug 13.0p

2022

2.40%

42.0p

17 Mar 26.0p 18 Aug 16.0p

2023

2.55%

49.4p

23 Mar 29.5p 10 Aug 19.9p

2024

3.11%

61.4p

21 Mar 37.1p 15 Aug 24.3p

2025

3.39%

64.6p

20 Mar 37.2p 14 Aug 27.3p

2026 This year

4.79%

66.4p

19 Mar 35.3p 14 Aug 31.1p

2027 Projection

4.48%

68.3p

19 Mar 37.2p 14 Aug 31.1p

Year	Ex-date	Declared	Record	Payment	Period	Value
2026	19 Mar 2026	26 Feb 2026	-	30 Apr 2026	Final	0.3529 GBP
2025	14 Aug 2025	07 Aug 2025	-	18 Sep 2025	Interim	0.2734 GBP
2025	20 Mar 2025	26 Feb 2025	-	01 May 2025	Final	0.3721 GBP
2024	15 Aug 2024	08 Aug 2024	15 Aug 2024	20 Sep 2024	Interim	0.2426 GBP
2024	21 Mar 2024	22 Feb 2024	21 Mar 2024	03 May 2024	Final	0.3714 GBP
2023	10 Aug 2023	03 Aug 2023	10 Aug 2023	15 Sep 2023	Interim	0.1988 GBP
2023	23 Mar 2023	23 Feb 2023	23 Mar 2023	05 May 2023	Final	0.2952 GBP
2022	18 Aug 2022	04 Aug 2022	18 Aug 2022	20 Sep 2022	Interim	0.1600 GBP
2022	17 Mar 2022	24 Feb 2022	17 Mar 2022	28 Apr 2022	Final	0.2600 GBP
2021	19 Aug 2021	06 Aug 2021	19 Aug 2021	20 Sep 2021	Interim	0.1300 GBP
2021	18 Mar 2021	25 Feb 2021	18 Mar 2021	26 Apr 2021	Final	0.2470 GBP
2020	20 Aug 2020	07 Aug 2020	20 Aug 2020	21 Sep 2020	Interim	0.1200 GBP
2020	19 Mar 2020	27 Feb 2020	19 Mar 2020	07 May 2020	Final	0.2422 GBP
2019	22 Aug 2019	09 Aug 2019	22 Aug 2019	23 Sep 2019	Interim	0.1400 GBP

Upcoming Dividends

Declared and projected dividend cycle

Ex-date	Status	Period	Dividend	Est. yield
14 Aug 2026	Predicted	Interim	0.3113 GBP	2.04%
19 Mar 2027	Predicted	Final	0.3721 GBP	2.44%

Recovery Speed

Recovered by trading week

1 <= 5d trading days

2 <= 10d trading days

2 <= 15d trading days

2 <= 20d trading days

2 <= 25d trading days

3 <= 30d trading days

Recovery Signature

Post ex-div behaviour

Median recovery9dtrading days to regain pre-ex close

Recovered50.00%events recovered inside 6w

Drop capture105.52%ex-drop as share of dividend paid

Score49speed, consistency, and drift blend

Bold white line = average visible recovery curve 6 events selected